Pull to refresh
Logo
Daily Brief
Following
Why Ranks Sign Up
Quantum hardware financing surge of 2026

Quantum hardware financing surge of 2026

Money Moves

Fidelity, BlackRock and Nvidia bet billions on quantum startups years before commercial revenue

Yesterday: Nord Quantique financing becomes public

Overview

Fidelity Investments led a $30 million round into Nord Quantique in March 2026, setting a $1.4 billion post-money valuation for the Sherbrooke, Quebec quantum hardware startup. The deal came to light May 15, making Nord Quantique the fourth Canadian-founded quantum company to cross a billion-dollar valuation.

Quantinuum filed its S-1 with the SEC on May 8, targeting a Nasdaq listing under the ticker QNT at a valuation above $20 billion. No quantum hardware company has priced at public-market scale before. Nord Quantique hired Tammy Furlong as CFO on May 12, bringing 25 years of pre-IPO finance experience to a company that has yet to post meaningful commercial revenue.

Why it matters

Investors are betting billions on quantum hardware that may not produce commercial revenue until 2033, testing whether institutional patience can last that long.

Key Indicators

$1.4B
Nord Quantique valuation
Post-money valuation set by the Fidelity-led round closed in March 2026.
$30M
Round size
Cash raised in the Fidelity-led round, modest by quantum hardware standards.
4
Canadian quantum unicorns
Nord Quantique joins D-Wave, Xanadu and Photonic in the billion-dollar club.
374%
2025 funding jump
Year-over-year increase in quantum startup financing, totaling $4.53B across 32 deals.
2033
DARPA utility-scale target
Year by which DARPA's Quantum Benchmarking Initiative aims to validate a useful quantum computer.

Interactive

Exploring all sides of a story is often best achieved with Play.

Ever wondered what historical figures would say about today's headlines?

Sign up to generate historical perspectives on this story.

People Involved

Organizations Involved

Timeline

  1. Nord Quantique financing becomes public

    Disclosure

    The Globe and Mail reports the March 2026 round, making Nord Quantique the fourth Canadian-founded quantum company to cross a billion-dollar valuation.

  2. Nord Quantique appoints Tammy Furlong as CFO

    Personnel

    Furlong joins from Elevation Oncology, where she served as CFO. She brings 25 years in pre-IPO biotech and infrastructure finance to guide Nord Quantique's financial strategy and industrialization path.

  3. Quantinuum publicly files S-1 for Nasdaq IPO under ticker QNT

    IPO

    Honeywell's quantum computing subsidiary files a registration statement with the SEC seeking to raise up to $1.5 billion at a valuation above $20 billion. J.P. Morgan and Morgan Stanley are lead underwriters. Pricing is expected in mid-June 2026.

  4. Nord Quantique closes $30M Fidelity-led round

    Funding

    Fidelity leads the round at a $1.4B post-money valuation. The financing was kept private at the time of close.

  5. Nord Quantique receives CAD$23M Quantum Champions grant

    Government

    Canadian federal program awards Nord Quantique non-dilutive funding to support hardware buildout and team expansion.

  6. Nord Quantique selected for DARPA Stage B

    Government

    Nord Quantique wins a $5M contract, extendable to $15M, to deliver an engineering roadmap for utility-scale quantum computing by 2033.

  7. Fidelity joins Quantinuum's $800M round at $10B valuation

    Funding

    Fidelity International makes its first quantum hardware investment as Quantinuum's oversubscribed round expands from $600M to $800M.

  8. PsiQuantum raises $1B Series E at $7B valuation

    Funding

    BlackRock, Temasek and Baillie Gifford lead the round, with Nvidia's NVentures arm joining. PsiQuantum will build utility-scale sites in Brisbane and Chicago.

  9. Nord Quantique closes CAD$9.5M seed round

    Funding

    BDC Capital's Deep Tech Venture Fund and Paris-based Quantonation co-lead the seed round, with Real Ventures participating.

  10. Nord Quantique spins out of Institut Quantique

    Founding

    Julien Camirand Lemyre and Philippe St-Jean launch Nord Quantique out of the Université de Sherbrooke's quantum research institute.

Scenarios

Predict which scenario wins. Contrarian picks score more — points lock in when the scenario resolves.

Log in to predict. Track your picks, climb the leaderboard. Log in Sign Up
1

Nord Quantique raises Series B above $2 billion before end of 2027

With Fidelity now anchoring its cap table and DARPA Stage B validation in hand, Nord Quantique is positioned to raise again before its current cash and government funding run out. Quantinuum and PsiQuantum each moved from billion-dollar rounds to multi-billion valuations within 18 months of similar inflection points.

Resolves by: 2027-12-31
Source: Nord Quantique press release or PitchBook profile
Discussed by: BetaKit, The Globe and Mail
Consensus
2

Pure-play quantum hardware company prices an IPO at $20B+ in 2026

Quantinuum confidentially filed an S-1 with the SEC and is targeting a valuation north of $20 billion. PsiQuantum is the other public-market candidate. A successful pricing would mark the first true exit at scale in the modern quantum hardware cycle.

Resolves by: 2026-12-31
Source: SEC EDGAR filings and exchange pricing data
Discussed by: AdValorem, SpinQ, Inside Quantum Technology
Consensus
3

Quantum financing in 2026 exceeds 2025's $4.53 billion total

2025 set a record at $4.53 billion across 32 deals. PsiQuantum, Quantinuum and Nord Quantique have already committed close to $2 billion in the past nine months. Continued institutional appetite would confirm quantum as a durable allocation rather than a momentum trade.

Resolves by: 2027-02-28
Source: PitchBook or Crunchbase year-end quantum sector report
Discussed by: The Quantum Insider, New Market Pitch
Consensus
4

Quantum financing pulls back in 2027 as commercial revenue stays elusive

If IBM's 2029 Starling fault-tolerant milestone slips or sector revenue stays under $1 billion through 2026, institutional patience could thin. A pullback would mirror the 2010s cleantech freeze after similar gaps between promise and revenue.

Resolves by: 2028-02-28
Source: PitchBook quantum sector annual report
Discussed by: TipRanks, SpinQ analysts
Consensus

Higher or Lower

Two numbers from this story. Guess which is bigger. Up to 5 rounds — one wrong call ends the streak.

Log in to play. Track your streak, climb the leaderboard. Log in Sign Up
Example
Anchor
EU tariff revenue
$52B
Mystery
Pentagon AI contract
?

Historical Context

AI foundation model funding surge (2023-2024)

2023-2024

What Happened

OpenAI, Anthropic, Mistral and xAI raised more than $30 billion combined to build large language models that had minimal commercial revenue at the time of investment. Microsoft alone committed $10 billion to OpenAI in January 2023. Multibillion-dollar valuations preceded any clear unit economics.

Outcome

Short Term

Capital concentration drove rapid compute buildout and a race for model scale. Independent labs that could not raise at scale were forced into acquihires or pivots.

Long Term

The sector ended 2024 with commercial revenue still concentrated in a handful of incumbents. Whether revenue catches up to invested capital is still an open question.

Why It's Relevant Today

Quantum financing follows the same playbook: institutional capital backs hardware-heavy companies years before commercial revenue. The open bet is whether quantum follows AI's revenue trajectory or stalls.

Biotech IPO wave anchored by Genentech (1980)

October 1980

What Happened

Genentech went public in October 1980 with no commercial product. The stock priced at $35 and traded above $80 within an hour. Cetus, Biogen and Genex followed. Roughly $500 million flowed into early biotech from institutional investors.

Outcome

Short Term

The first wave of public capital let companies build production capacity for commercial biologics. Most of the 1980 cohort took 5 to 10 years to ship a drug.

Long Term

Genentech produced the first recombinant human insulin in 1982 and was acquired by Roche in 2009 for $46.8 billion. The category proved investors right, though the timeline stretched well beyond initial expectations.

Why It's Relevant Today

Like biotech in 1980, quantum companies are raising billions before commercial revenue exists. Genentech shows the pattern can work. It also shows how long the lag between financing and validation can run.

Cleantech investment freeze (2008-2012)

2008-2012

What Happened

Venture capital poured roughly $25 billion into cleantech between 2006 and 2011. Solyndra, A123 Systems and Fisker Automotive all collapsed. MIT Energy Initiative researchers later estimated investors lost more than half their capital in the cohort.

Outcome

Short Term

Series funding for cleantech hardware froze for nearly a decade. Surviving companies pivoted to software-heavier business models.

Long Term

The sector recovered by 2020 as battery costs fell and policy support returned. Tesla and a few others vindicated the original thesis, though most early investors did not see returns.

Why It's Relevant Today

Cleantech shows what happens when capital-intensive deep tech misses commercialization deadlines: a multi-year funding winter. Quantum's 2033 utility-scale target gives it a comparable runway problem if the milestone slips.

Sources

(12)